| 1 |
Minen MT , Begasse De Dhaem O , Kroon Van Diest A , Powers S , Schwedt TJ , Lipton R , Silbersweig D . Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry, 2016, 87: 741- 749.
doi: 10.1136/jnnp-2015-312233
|
| 2 |
George A , Minen MT . Episodic migraine and psychiatric comorbidity: a narrative review of the literature. Curr Pain Headache Rep, 2023, 27: 461- 469.
doi: 10.1007/s11916-023-01123-4
|
| 3 |
Katsarava Z , Buse DC , Leroux E , Lanteri-Minet M , Sakai F , Matharu MS , Adams AM , Carr K , Fanning KM , Lipton RB . Disability in migraine: multicountry results from the Chronic Migraine Epidemiology and Outcomes-International (CaMEO-Ⅰ) Study. Cephalalgia, 2024, 44: 3331024241274343.
doi: 10.1177/03331024241274343
|
| 4 |
Merikangas AK , Schultz LM , Ruparel K , Lateef T , Gur RE , Almasy L . Do common genetic factors underlie comorbidity between migraine and major depressive disorder in youth?. Pediatr Neurol, 2025, 173: 166- 172.
doi: 10.1016/j.pediatrneurol.2025.09.017
|
| 5 |
Cui Y , Wang S . Association between psychological disorders and migraine in young U.S. adults with gender-specific analysis and marital status considerations. J Headache Pain, 2025, 26: 267.
doi: 10.1186/s10194-025-02226-6
|
| 6 |
Schwedt TJ . Chronic migraine. BMJ, 2014, 348: g1416.
doi: 10.1136/bmj.g1416
|
| 7 |
Hsu JW , Tsai SJ , Chang WH , Cheng CM , Bai YM , Su TP , Chen TJ , Chen MH . Risks and familial coaggregation of suicide, accident mortality, and psychiatric disorders in first-degree relatives of individuals with migraine. J Pain, 2025, 29: 105335.
doi: 10.1016/j.jpain.2025.105335
|
| 8 |
Wang YX , Lu GS , Zhao JJ , Dai W , Zheng N , Yao GE , Liu RZ . The burden of migraine and predictions in the Asia-Pacific region, 1990-2021: a comparative analysis of China, South Korea, Japan, and Australia. J Headache Pain, 2025, 26: 104.
doi: 10.1186/s10194-025-02048-6
|
| 9 |
Asif N , Patel A , Vedantam D , Poman DS , Motwani L . Migraine with comorbid depression: pathogenesis, clinical implications, and treatment. Cureus, 2022, 14: e25998.
|
| 10 |
Giri S , Tronvik EA , Hagen K . The bidirectional temporal relationship between headache and affective disorders: longitudinal data from the HUNT studies. J Headache Pain, 2022, 23: 14.
doi: 10.1186/s10194-022-01388-x
|
| 11 |
Johnson M , Filali Y , Adegboyo A , Eberle M , Townsend A , Hussien Y , Marcinkiewcz C , Hultman R . Mechanistic intersections between migraine and major depressive disorder. J Headache Pain, 2025, 26: 157.
doi: 10.1186/s10194-025-02097-x
|
| 12 |
Affatato O , Dahlén AD , Rukh G , Schiöth HB , Mwinyi J . Assessing volumetric brain differences in migraine and depression patients: a UK Biobank study. BMC Neurol, 2023, 23: 284.
doi: 10.1186/s12883-023-03336-x
|
| 13 |
Zhang Y , Liu Y , Han R , Liu K , Xing Y . Hypoechogenicity of the midbrain raphe detected by transcranial sonography: an imaging biomarker for depression in migraine patients. Ther Adv Neurol Disord, 2021, 14: 17562864211007708.
doi: 10.1177/17562864211007708
|
| 14 |
Chen W , Xie G , Xu C , Liang J , Zhang C . The relationship between regional homogeneity in resting-state functional magnetic resonance imaging and cognitive function in depressive disorders with migraine. Sci Rep, 2025, 15: 11810.
doi: 10.1038/s41598-025-96850-6
|
| 15 |
Yang Y , Wei K , Zhang H , Hu H , Yan L , Gui W , Liu Y , Chen X . Identifying functional brain abnormalities in migraine and depression comorbidity. Quant Imaging Med Surg, 2022, 12: 2288- 2302.
doi: 10.21037/qims-21-667
|
| 16 |
Zhang Z , Xie C , Dong L , Zeng L , Sun M , Fu Q , Ouyang X , Yan Q , Wang T , Zhang Q , Wang X , Zhao L . Unveiling state-specific neural dynamics in migraine with and without depressive symptom: a hidden Markov model and interpretable machine learning approach. J Headache Pain, 2026, 27: 103.
doi: 10.1186/s10194-026-02320-3
|
| 17 |
Hamel E . Serotonin and migraine: biology and clinical implications. Cephalalgia, 2007, 27: 1293- 1300.
doi: 10.1111/j.1468-2982.2007.01476.x
|
| 18 |
Bhatt S , Devadoss T , Manjula SN , Rajangam J . 5-HT3 receptor antagonism a potential therapeutic approach for the treatment of depression and other disorders. Curr Neuropharmacol, 2021, 19: 1545- 1559.
doi: 10.2174/1570159X18666201015155816
|
| 19 |
Viudez-Martínez A , Torregrosa AB , Navarrete F , García-Gutiérrez MS . Understanding the biological relationship between migraine and depression. Biomolecules, 2024, 14: 163.
doi: 10.3390/biom14020163
|
| 20 |
Kuner R , Kuner T . Cellular Circuits in the brain and their modulation in acute and chronic pain. Physiol Rev, 2021, 101: 213- 258.
doi: 10.1152/physrev.00040.2019
|
| 21 |
Liu TT , Chen SP , Wang SJ , Yen JC . Vagus nerve stimulation inhibits cortical spreading depression via glutamate-dependent TrkB activation mechanism in the nucleus tractus solitarius. Cephalalgia, 2024, 44: 3331024241230466.
doi: 10.1177/03331024241230466
|
| 22 |
Jain R , Chepke C , Davis LL , McIntyre RS , Raskind MA . Dysregulation of noradrenergic activity: its role in conceptualizing and treating major depressive disorder, schizophrenia, agitation in Alzheimer's disease, and posttraumatic stress disorder. J Clin Psychiatry, 2024, 85: plunaro2417ah.
|
| 23 |
Hjelholt AJ , Tei RMH , Diener HC , Jørgensen JOL . Dopamine and prolactin in migraine: mechanisms and potential therapeutic targets. J Neuroendocrinol, 2025, 37: e70098.
doi: 10.1111/jne.70098
|
| 24 |
Yan W , Gao Q , Zhou Y , Xu P , Wu Z , Yuan T , Xie L , You Z , Zhang X , Feng B , Yang S , Chen Y , Xiong M . Human stem cell-derived A10 dopaminergic neurons specifically integrate into mouse circuits and improve depression-like behaviors. Cell Stem Cell, 2025, 32: 1457- 1474.
doi: 10.1016/j.stem.2025.07.007
|
| 25 |
Sarawagi A , Soni ND , Patel AB . Glutamate and GABA homeostasis and neurometabolism in major depressive disorder. Front Psychiatry, 2021, 12: 637863.
doi: 10.3389/fpsyt.2021.637863
|
| 26 |
Peek AL , Leaver AM , Foster S , Puts NA , Oeltzschner G , Henderson L , Galloway G , Ng K , Refshauge K , Rebbeck T . Increase in ACC GABA+ levels correlate with decrease in migraine frequency, intensity and disability over time. J Headache Pain, 2021, 22: 150.
doi: 10.1186/s10194-021-01352-1
|
| 27 |
Wattiez AS , Wang M , Russo AF . CGRP in animal models of migraine. Handb Exp Pharmacol, 2019, 255: 85- 107.
|
| 28 |
Omaer A , Albilali A , Bamogaddam R , Almutairi F , Alsaif R , Almohammadi O , Alhifany AA . Improvement of comorbid anxiety and depression in patients with migraine treated with injectable preventive calcitonin gene-related peptide antagonists: review of clinical evidence. Saudi Pharm J, 2024, 32: 101989.
doi: 10.1016/j.jsps.2024.101989
|
| 29 |
de Vries Lentsch S , van der Arend BWH , de Boer I , van Zwet EW , MaassenVanDenBrink A , Terwindt GM . Depression and treatment with anti-calcitonin gene related peptide (CGRP) (ligand or receptor) antibodies for migraine. Eur J Neurol, 2024, 31: e16106.
doi: 10.1111/ene.16106
|
| 30 |
Driessen MT , Cohen JM , Thompson SF , Patterson-Lomba O , Seminerio MJ , Carr K , Totev TI , Sun R , Yim E , Mu F , Ayyagari R . Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine. J Headache Pain, 2022, 23: 56.
doi: 10.1186/s10194-022-01415-x
|
| 31 |
Egodage UK , Mohideen MS , Mohotti SP . Sex differences in migraine: bridging pathophysiology and clinical care in women. Adv Physiol Educ, 2025, 49: 1109- 1115.
doi: 10.1152/advan.00020.2025
|
| 32 |
Labastida-Ramírez A , Rubio-Beltrán E , Villalón CM , MaassenVanDenBrink A . Gender aspects of CGRP in migraine. Cephalalgia, 2019, 39: 435- 444.
doi: 10.1177/0333102417739584
|
| 33 |
Martin VT , Behbehani M . Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis, part Ⅰ. Headache, 2006, 46: 3- 23.
doi: 10.1111/j.1526-4610.2006.00309.x
|
| 34 |
Chhibber A , Woody SK , Karim Rumi MA , Soares MJ , Zhao L . Estrogen receptor β deficiency impairs BDNF-5-HT2A signaling in the hippocampus of female brain: a possible mechanism for menopausal depression. Psychoneuroendocrinology, 2017, 82: 107- 116.
doi: 10.1016/j.psyneuen.2017.05.016
|
| 35 |
Yang Y , Zhao H , Boomsma DI , Ligthart L , Belin AC , Smith GD , Esko T , Freilinger TM , Hansen TF , Ikram MA , Kallela M , Kubisch C , Paraskevi C , Strachan DP , Wessman M , International Headache Genetics Consortium , van den Maagdenberg AMJM , Terwindt GM , Nyholt DR . Molecular genetic overlap between migraine and major depressive disorder. Eur J Hum Genet, 2018, 26: 1202- 1216.
doi: 10.1038/s41431-018-0150-2
|
| 36 |
Liang G , Huang Q , Song W , Pan M , Wei Q , Zeng J , Xie Y , Lan Y , Zou C , Liu X , Huang X , Zou D . Neuroimmune dysregulation and comorbidity mechanisms of major depressive disorder and migraine. BMC Psychiatry, 2026, 26: 44.
doi: 10.1186/s12888-025-07473-0
|
| 37 |
Hu S , Tang Z , Ouyang X , Sun S , Xu L , Yuan J , Zhao L . Peripheral innate immune signature links migraine and depression: identification of PTX3 and HP as shared diagnostic biomarkers. J Affect Disord, 2026, 392: 120311.
doi: 10.1016/j.jad.2025.120311
|
| 38 |
Grangeon L , Lange KS , Waliszewska-Prosół M , Onan D , Marschollek K , Wiels W , Mikulenka P , Farham F , Gollion C , Ducros A . European Headache Federation School of Advanced Studies (EHF-SAS). Genetics of migraine: where are we now?. J Headache Pain, 2023, 24: 12.
doi: 10.1186/s10194-023-01547-8
|
| 39 |
Sutherland HG , Jenkins B , Griffiths LR . Genetics of migraine: complexity, implications, and potential clinical applications. Lancet Neurol, 2024, 23: 429- 446.
doi: 10.1016/S1474-4422(24)00026-7
|
| 40 |
Cabañero D , Carter EP , González-Cano R , Cobos EJ , Fernández-Carvajal A , Ferrer-Montiel A . Cold receptor TRPM8 as a target for migraine-associated pain and affective comorbidities. J Headache Pain, 2025, 26: 146.
doi: 10.1186/s10194-025-02082-4
|
| 41 |
Meng Z , Song Y , Jiang Y , Wang X , Zou Y , Li X , Hakonarson H , Chang X . Transformer-based deep learning enhances discovery in migraine GWAS. Nat Commun, 2025, 16: 11023.
doi: 10.1038/s41467-025-65991-7
|
| 42 |
Androulakis XM , Yu X , Zhu X , Thiam MA , Cai G . Migraine and major depression: localizing shared genetic susceptibility in different cell types of the nervous systems. Front Neurol, 2023, 14: 1254290.
doi: 10.3389/fneur.2023.1254290
|
| 43 |
Swanson SA , Zeng Y , Weeks M , Colman I . The contribution of stress to the comorbidity of migraine and major depression: results from a prospective cohort study. BMJ Open, 2013, 3: e002057.
doi: 10.1136/bmjopen-2012-002057
|
| 44 |
Zhang M , Dai W , Liang J , Chen X , Hu Y , Chu B , Pan M , Dong Z , Yu S . Effects of UCMS-induced depression on nociceptive behaviors induced by electrical stimulation of the dura mater. Neurosci Lett, 2013, 551: 1- 6.
|
| 45 |
Lumertz FS , Kestering-Ferreira E , Orso R , Creutzberg KC , Tractenberg SG , Stocchero BA , Viola TW , Grassi-Oliveira R . Effects of early life stress on brain cytokines: a systematic review and meta-analysis of rodent studies. Neurosci Biobehav Rev, 2022, 139: 104746.
doi: 10.1016/j.neubiorev.2022.104746
|
| 46 |
Chinese Society of Neurology , Headache Group of Chinese Society of Neurology . Chinese practice guidelines for diagnosis and treatment of migraine (1st edition, Chinese Society of Neurology). Zhonghua Shen Jing Ke Za Zhi, 2023, 56: 591- 613.
|
|
中华医学会神经病学分会, 中华医学会神经病学分会头痛协作组. 中国偏头痛诊断与治疗指南(中华医学会神经病学分会第一版). 中华神经科杂志, 2023, 56: 591- 613.
|
| 47 |
Hedayat M , Nazarbaghi S , Heidari M , Sharifi H . Venlafaxine can reduce the migraine attacks as well as amitriptyline: a noninferiority randomized trial. Clin Neurol Neurosurg, 2022, 214: 107151.
doi: 10.1016/j.clineuro.2022.107151
|
| 48 |
Hung CI , Liu CY , Yang CH , Wang SJ . Migraine and greater pain symptoms at 10-year follow-up among patients with major depressive disorder. J Headache Pain, 2018, 19: 56.
doi: 10.1186/s10194-018-0884-9
|
| 49 |
Bolchini M , Ceccardi G , Schiano di Cola F , Di Pasquale M , Rao R , Padovani A . Anti-CGRP monoclonal antibodies, migraine and mood disorders: an observational study. Neurol Sci, 2025, 46: 4515- 4526.
doi: 10.1007/s10072-025-08372-8
|
| 50 |
Oshima K , Hattori Y , Ihara K , Watanabe N , Takemura R , Ishizuchi K , Takahashi N , Sekiguchi K , Nakahara J , Takizawa T . Effect of galcanezumab on PHQ-9 and GAD-7 in patients with migraine: a real-world study in Japan. Intern Med, 2026, 65: 802- 809.
doi: 10.2169/internalmedicine.5856-25
|
| 51 |
Lipton RB , Ramirez Campos V , Roth-Ben Arie Z , Galic M , Mitsikostas D , Tassorelli C , Denysenko L , Cohen JM . Fremanezumab for the treatment of patients with migraine and comorbid major depressive disorder: the UNITE randomized clinical trial. JAMA Neurol, 2025, 82: 560- 569.
doi: 10.1001/jamaneurol.2025.0806
|
| 52 |
Dai TC , Tang WY , Du PP . Effects of duloxetine on neuroelectrophysiological indexes and related factors of nerve function in patients with Chronic migraine with anxiety and depression. Guo Ji Jing Shen Bing Xue Za Zhi, 2025, 52: 943- 947.
|
|
戴太铖, 唐文艳, 杜培培. 度洛西汀对慢性偏头痛伴焦虑抑郁患者神经电生理指标及神经功能相关因子的影响. 国际精神病学杂志, 2025, 52: 943- 947.
|
| 53 |
Wang R , Song HL , Xu F . Effect of Modified Danzhi Xiaoyao Powder (加味丹栀逍遥散) combined with "soothing liver and regulating spirit" acupuncture on cognitive function and prognosis of patients with migraine accompanied by depression and anxiety disorder. Zhonghua Zhong Yi Yao Xue Kan, 2024, 42: 183- 186.
|
|
王榕, 宋汉琳, 徐福. 加味丹栀逍遥散联合疏肝调神针法对偏头痛伴抑郁焦虑障碍认知功能及预后的影响. 中华中医药学刊, 2024, 42: 183- 186.
|
| 54 |
He J , Jiang YL , Gao JC , Zou LJ . A randomized controlled trial on Shu-point acupuncture combined with needle-warming moxibustion in treatment of migraine with comorbid anxiety and depression. Zhen Jiu Lin Chuang Za Zhi, 2025, 41: 44- 48.
|
|
何婧, 蒋一璐, 高菊聪, 邹露娟. 输刺法与温针灸联合治疗偏头痛合并焦虑抑郁患者的随机对照研究. 针灸临床杂志, 2025, 41: 44- 48.
|
| 55 |
Affatato O , Moulin TC , Pisanu C , Babasieva VS , Russo M , Aydinlar EI , Torelli P , Chubarev VN , Tarasov VV , Schiöth HB , Mwinyi J . High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis. J Transl Med, 2021, 19: 133.
doi: 10.1186/s12967-021-02801-w
|
| 56 |
Blumenfeld AM , Tepper SJ , Robbins LD , Manack Adams A , Buse DC , Orejudos A , D Silberstein S . Effects of onabotulinumtoxin A treatment for chronic migraine on common comorbidities including depression and anxiety. J Neurol Neurosurg Psychiatry, 2019, 90: 353- 360.
doi: 10.1136/jnnp-2018-319290
|
| 57 |
Tereshko Y , Lettieri C , Belgrado E , Pez S , Gigli GL , Valente M . Efficacy and safety of two different botulinum toxin type A dilutions in chronic migraineurs. Toxicon, 2023, 227: 107096.
doi: 10.1016/j.toxicon.2023.107096
|
| 58 |
Desarkar P , Vicario CM , Soltanlou M . Non-invasive brain stimulation in research and therapy. Sci Rep, 2024, 14: 29334.
doi: 10.1038/s41598-024-79039-1
|
| 59 |
Markin K , Trufanov A , Frunza D , Litvinenko I , Tarumov D , Krasichkov A , Polyakova V , Efimtsev A , Medvedev D . fMRI findings in cortical brain networks interactions in migraine following repetitive transcranial magnetic stimulation. Front Neurol, 2022, 13: 915346.
doi: 10.3389/fneur.2022.915346
|
| 60 |
Seng EK , Hill J , Reeder AK , Visvanathan P , Wells RE , Lipton RB , Minen M , Shallcross AJ . Feasibility, acceptability, and fidelity of remote-delivered abbreviated mindfulness-based cognitive therapy interventions for patients with migraine and depressive symptoms. Headache, 2025, 65: 545- 557.
doi: 10.1111/head.14857
|